{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:07Z","timestamp":1791181987967,"version":"4.1.0"},"reference-count":125,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2004,8,3]],"date-time":"2004-08-03T00:00:00Z","timestamp":1091491200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several emerging treatment concepts for myeloid neoplasms are based on novel drugs targeting cell surface antigens, signalling pathways, or critical effector molecules. Systemic mastocytosis is a haematopoietic neoplasm that behaves as an indolent myeloproliferative disease in most patients, but can also present as aggressive disease or even as an acute leukaemia. In patients with aggressive disease or mast cell leukaemia, the response to conventional therapy is poor in most cases, and the prognosis is grave. Therefore, a number of attempts have been made to define novel treatment strategies for these patients. One promising approach may be to identify novel targets and to develop targeted drug therapies. In this article, we support the notion that neoplastic mast cells indeed express a number of potential molecular targets including immunoreactive CD antigens, the microphthalmia transcription factor (MITF), and members of the Bcl\u20102 family. In addition, the tyrosine kinase receptor KIT and downstream signalling pathways have been proposed as targets of a specific pharmacological intervention. A particular challenge is the disease\u2010related D816V\u2010mutated variant of KIT, which is resistant against diverse tyrosine kinase inhibitors including STI571, but may be sensitive to more recently developed targeted compounds. The therapeutic potential of target\u2010specific approaches in malignant mast cell disorders should be evaluated in forthcoming clinical trials in the near future.<\/jats:p>","DOI":"10.1111\/j.0960-135x.2004.01369.x","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T09:25:19Z","timestamp":1091611519000},"page":"41-52","source":"Crossref","is-referenced-by-count":44,"title":["On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts"],"prefix":"10.1111","volume":"34","author":[{"given":"P.","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ghannadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010T.","family":"Krauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mayerhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Samorapoompichit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010P.","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,3]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1979.tb03017.x"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12468882"},{"key":"e_1_2_9_4_2","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent P","year":"1996","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198811000-00001"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12468899"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04575.x"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202273260912"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0396-312"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.23.10560"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1609"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048179"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(99)00145-9"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0203"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90214-I"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07870.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048186"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00040-6"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00038-8"},{"key":"e_1_2_9_21_2","first-page":"291","volume-title":"World Health Organization (WHO) Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues","author":"Valent P","year":"2001"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0575-z"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00168-6"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116761"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70294-X"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/mp.53.4.188"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048185"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00046-7"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.880"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<191::AID-AJH4>3.0.CO;2-Y"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00023-6"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00019-4"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00172-2"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3784"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00050-9"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048182"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61111-X"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118337"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199809000-00013"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70301-4"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048189"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000245681"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00044-3"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62636-6"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202273260907"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08689.x"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054789"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00663015"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02131.x"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101253440415"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1699"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342"},{"key":"e_1_2_9_55_2","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.151.8.4221","article-title":"Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c\u2010kit+, CD34+, Ly\u2013, CD14\u2013, CD17\u2013, colony forming cell","volume":"151","author":"Agis H","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_9_56_2","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/FceRI\u2013 cell population","volume":"84","author":"Rottem M","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.7.1778.1778"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60879-2"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.493578.x"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(02)00057-7"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.4.1237"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3197"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3244"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)00925-6"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.suppl_1.i109"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.790108.x"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70403-7"},{"key":"e_1_2_9_68_2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL\u20102 receptor \u03b1 chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin C","year":"2000","journal-title":"Blood"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048184"},{"key":"e_1_2_9_70_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood.V83.2.426.426","article-title":"Recombinant immunotoxins containing anti\u2010Tac (Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin\u20102 receptor\u2010expressing human carcinoma","volume":"83","author":"Kreitman RJ","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_71_2","first-page":"959","article-title":"Immunization against tumor cell surface complement\u2010regulatory proteins","volume":"2","author":"Durrant LG","year":"2001","journal-title":"Curr Opin Invest Drugs"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.00171.x"},{"key":"e_1_2_9_73_2","first-page":"3629","article-title":"Epitope\u2010specific antibody response to HT\u20101080 fibrosarcoma cells by mimotope immunization","volume":"6","author":"Popkov M","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_74_2","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human mast cells and basophils: Evidence for mast cell heterogeneity and C5aR\/CD88 expression on skin mast cells","volume":"155","author":"F\u00fcreder W","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04055.x"},{"issue":"2","key":"e_1_2_9_76_2","first-page":"S163","article-title":"Immunogenicity of CD63 in a patient with melanoma","volume":"7","author":"Smith M","year":"1997","journal-title":"Melanoma Res"},{"key":"e_1_2_9_77_2","first-page":"2343","article-title":"The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multi\u2010 and unipotent progenitors","volume":"94","author":"B\u00fchring HJ","year":"1999","journal-title":"Blood"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.15.10248"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1365"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31874-4"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.2.135"},{"key":"e_1_2_9_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00078-3"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07023.x"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.8.5.909"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.11.2880.2880"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14665"},{"key":"e_1_2_9_87_2","first-page":"139","article-title":"Abl protein\u2010tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c\u2010kit and platelet\u2010derived growth factor receptors","volume":"295","author":"Buchdunger E","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206120"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(03)00112-7"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1741"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0350"},{"key":"e_1_2_9_92_2","doi-asserted-by":"crossref","unstructured":"FumoG AkinC MetcalfeDD NeckersL.17\u2010allylamino\u201017\u2010demethoxy\u2010geldanamycin (17\u2010AAG) is effective in down\u2010regulating mutated constitutively activated KIT protein in human mast cells.Blood2004;103:1078\u201384.","DOI":"10.1182\/blood-2003-07-2477"},{"key":"e_1_2_9_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204091"},{"key":"e_1_2_9_94_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252462599"},{"key":"e_1_2_9_95_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast cells in  W\/W\n                  \n                     v\n                   mice and their increase by bone marrow transplantation","volume":"52","author":"Kitamura Y","year":"1978","journal-title":"Blood"},{"key":"e_1_2_9_96_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood.V53.3.492.492","article-title":"Decreased production of mast cells in Sl\/Sl\n                  \n                     d\n                   anemic mice","volume":"53","author":"Kitamura Y","year":"1979","journal-title":"Blood"},{"key":"e_1_2_9_97_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.V75.6.1247.1247","article-title":"Mechanism of mast cell deficiency in mutant mice of mi\/mi genotype: an analysis by co\u2010culture of mast cells and fibroblasts","volume":"75","author":"Ebi Y","year":"1990","journal-title":"Blood"},{"key":"e_1_2_9_98_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048178"},{"key":"e_1_2_9_99_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7878471"},{"key":"e_1_2_9_100_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3490"},{"key":"e_1_2_9_101_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3559"},{"key":"e_1_2_9_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00903-8"},{"key":"e_1_2_9_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03207-4"},{"key":"e_1_2_9_104_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1685"},{"key":"e_1_2_9_105_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3899"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90176-A"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(05)80005-6"},{"key":"e_1_2_9_108_2","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.163.5.2799","article-title":"Stem cell factor is localized in, released from, and cleaved by human mast cells","volume":"163","author":"De Paulis A","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1309\/71KH-4JE4-E0J1-7THH"},{"key":"e_1_2_9_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90326-T"},{"key":"e_1_2_9_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<164::AID-ANR21>3.0.CO;2-Z"},{"key":"e_1_2_9_112_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119336"},{"key":"e_1_2_9_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/346274a0"},{"key":"e_1_2_9_114_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0109"},{"key":"e_1_2_9_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0202-128"},{"key":"e_1_2_9_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-730"},{"key":"e_1_2_9_117_2","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood.V87.11.4754.bloodjournal87114754","article-title":"Characterization of a hierarchy of human acute myeloid leukemia progenitor cells","volume":"87","author":"Sutherland HJ","year":"1996","journal-title":"Blood"},{"key":"e_1_2_9_118_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401903"},{"key":"e_1_2_9_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402744"},{"key":"e_1_2_9_120_2","unstructured":"Feuring\u2010BuskeM FrankelAE AlexanderRL GerhardB HoggeDEA.Diphtheria toxin\u2010interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.Cancer Res2002;62:1730\u20136."},{"key":"e_1_2_9_121_2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/1381612805666230112210149","article-title":"The role of interferon\u2010\u03b1 in the treatment of myeloproliferative disorders","volume":"5","author":"Fiorani C","year":"1999","journal-title":"Curr Pharm Des"},{"key":"e_1_2_9_122_2","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.135.4.2502","article-title":"The synergistic influence of human interferon\u2010gamma and interferon\u2010\u03b1 on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro","volume":"135","author":"Broxmeyer HE","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_9_123_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199221000-00003"},{"key":"e_1_2_9_124_2","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood.V84.9.2954.2954","article-title":"Origin of human mast cells: Development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation","volume":"84","author":"F\u00f6dinger M","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_125_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000206"},{"key":"e_1_2_9_126_2","doi-asserted-by":"crossref","unstructured":"HauswirthAW Simonitsch\u2010KluppI UffmannM KollerE SperrWR LechnerKet al.Response to therapy with interferon \u03b1\u20102b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.Leuk Res2004;28:249\u201357.","DOI":"10.1016\/S0145-2126(03)00259-5"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0960-135X.2004.01369.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0960-135X.2004.01369.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:28:31Z","timestamp":1695713311000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0960-135X.2004.01369.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":125,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.0960-135X.2004.01369.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0960-135x.2004.01369.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}